Drug

Eli Lilly’s Trulicity + Insulin Combo Meets Goals in China’s AWARD-CHN3 Study

Policy / Regulatory

China’s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids

CompanyDrug

CDE Grants Priority Review to Ascentage’s Olerembatinib and Roche’s Crovalimab

CompanyDeals

Athenex Sells China Subsidiaries to TiHe Capital for USD 19 Million

CompanyDeals

Tasly Pharmaceuticals and Mauna Kea Form JV to Commercialize Cellvizio in China

CompanyMedical Device

MicroPort MedBot’s Honghu Robot Wins FDA 510(k) Certification for Joint Replacement

CompanyMedical Device

Venus Medtech’s Transcatheter Prosthetic Pulmonary Valve Approved by NMPA

CompanyDrug

Hengrui Medicine’s SHR-1701 + Ameile Combo Greenlit for EGFR-Mutated NSCLC Trial

CompanyDrug

Eucure Biopharma Doses First Patient in YH003 + Keytruda Trial for Mucosal Melanoma

CompanyDrug

Overland ADCT BioPharma Launches Global Phase III Trial for Zynlonta in DLBCL

CompanyDrug

Bio-Thera Solutions Doses First Patient in BAT8006 Phase I Study for Solid Tumors

CompanyDeals

Neurophth and Abogen Partner on mRNA Therapy for Retinal Diseases